DTU and ORCA validate quantum-AI peptide design in lab tests
A July 9th preprint says a photonic quantum processor helped a generative model find MHC-binding peptides where data was scarce.
By Ryan Merket · Published
Primary source: Aligned News - AI Intelligence
Why it matters
Quantum-computing companies need near-term use cases customers can evaluate. DTU and ORCA's peptide work gives the field a modest but testable loop: use quantum-derived sampling to improve AI shortlists, then let the lab decide.
Timothy Patrick Jenkins and ORCA Computing CEO Richard Murray have something the quantum-computing market badly needs: a wet-lab result tied to a near-term use case. A Technical University of Denmark team led by Jenkins used a hybrid generative-AI and quantum-computing workflow to design novel MHC class I-binding peptides, then validated selected designs in vitro, according to a [WIRED…